• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconOncology

Oncology

Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in overall survival in people with germline BRCA-mutated (gBRCAm), HER2-negative high-risk early breast cancer, 2024 clinical trial data suggest.
HealthMerck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
By Lindsey LeakeDecember 20, 2024
Women embracing after finishing breast cancer awareness race.
HealthScientists discover evidence of 4 more breast cancer genes—and potentially many others: ‘The risks can be significant for women who carry them’
By Erin PraterAugust 17, 2023
A woman in an Allcyte lab coat looking at images of cancer cells on a screen.
TechBritish A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company
By Jeremy KahnJune 15, 2021
Microscopy image of cancer cells
TechThis startup has found a way to uncover bespoke cancer therapies
By Jeremy KahnMarch 25, 2021
A line of syringes shown in silhouette against the AstraZeneca corporate logo.
FinanceAstraZeneca’s stock is soaring on COVID, but the pandemic has dented its growth
By Jeremy KahnNovember 6, 2020
How reborn pharma giant AstraZeneca is taking the lead against COVID-19
MagazineHow reborn pharma giant AstraZeneca is taking the lead against COVID-19
By Jeremy KahnAugust 10, 2020
Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
HealthCancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
By Riley Griffin, James Paton and BloombergDecember 9, 2019
How to Innovate at Flatiron Health? It Starts With a Hackathon
HealthHow to Innovate at Flatiron Health? It Starts With a Hackathon
By Andrew NuscaJuly 31, 2018
Gilead Takes AIDS Drug-Cocktail Approach To Fighting Cancer
HealthGilead’s New Cancer Gene Therapy Has Been Approved by the FDA
By ReutersOctober 18, 2017
2017 Newport Folk Festival
LeadershipHere Are This Year’s MacArthur ‘Genius’ Grant Winners
By Natasha BachOctober 11, 2017
Kim Le, a research associate for FivePrime Therapeutics, wor
HealthThis Obscure Biotech Company May Have a Game-Changing Cancer Med On Its Hands
By Sy MukherjeeJune 6, 2016
pancreatic cancer cell
TechStudy Finds Targeted Cancer Drugs May Work in Range of Tumor Types
By ReutersJune 4, 2016
Israeli Laboratory Leads Western World In Blood Testing
TechA Blood Test for Cancer Gets Closer
By TIMEJune 4, 2016
Chicago skyscrapers
HealthWhat You Need to Know About the World’s Biggest Cancer Conference
By Sy MukherjeeJune 2, 2016
This Microscope Can Detect Cancer Without a Biopsy
HealthThis Microscope Can Detect Cancer Without a Biopsy
By Hilary BrueckJanuary 28, 2016
1
  • 1
  • 2
2
Most Popular
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regretsplaceholder alt text
By Preston ForeApril 27, 2026
Banking
‘They left me no choice’: Powell isn’t going anywhere—blocking Trump from another Fed appointeeplaceholder alt text
By Eva RoytburgApril 29, 2026
Economy
Jamie Dimon gets candid about national debt: ‘There will be a bond crisis, and then we’ll have to deal with it’placeholder alt text
By Eleanor PringleApril 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.